Non-adherence to hormonal therapy in breast cancer survivors
Research type
Research Study
Full title
Non-adherence to hormonal therapy in breast cancer survivors: a qualitative analysis of the role of sleep disturbance
IRAS ID
276446
Contact name
Leanne Fleming
Contact email
Sponsor organisation
University of Strathclyde
Duration of Study in the UK
0 years, 6 months, 0 days
Research summary
Women with hormone-receptor-positive breast cancer are prescribed hormone therapy for 5-10 years after breast cancer surgery to minimise the risk of breast cancer recurrence. Research indicates that around 50% of women prescribed hormone therapy do not adhere to their prescription. In most cases, this is because of unpleasant side-effects from the medication. Sleep disturbance is one of the most common side-effects of hormone therapy, but its influence upon adherence has not yet been examined. We will qualitatively explore the experience of poor sleep and its impact on adherence to hormone therapy.
REC name
Yorkshire & The Humber - Leeds West Research Ethics Committee
REC reference
20/YH/0116
Date of REC Opinion
23 Apr 2020
REC opinion
Further Information Favourable Opinion